Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 17890873)

Published in Nephron Clin Pract on September 21, 2007

Authors

Daniel Zehnder1, Martin J Landray, David C Wheeler, William Fraser, Lisa Blackwell, Sarah Nuttall, Sue V Hughes, John Townend, Charles Ferro, Colin Baigent, Martin Hewison

Author Affiliations

1: Department of Nephrology, University Hospital Coventry and Warwickshire NHS Trust, Coventry, UK. d.zehnder@warwick.ac.uk

Articles citing this

Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis (2010) 1.65

Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol (2014) 1.40

Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. Clin J Am Soc Nephrol (2010) 1.21

Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift? Nat Clin Pract Nephrol (2008) 0.98

Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis. Am J Clin Nutr (2012) 0.94

Serum free light chains and the risk of ESRD and death in CKD. Clin J Am Soc Nephrol (2011) 0.86

Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation. PLoS One (2014) 0.80

Influence of Secondary Hyperparathyroidism Induced by Low Dietary Calcium, Vitamin D Deficiency, and Renal Failure on Circulating Rat PTH Molecular Forms. Int J Endocrinol (2011) 0.78

Vitamin D status of children receiving chronic dialysis. Pediatr Nephrol (2012) 0.77

Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis. BMC Nephrol (2013) 0.76

Risk factors of cardiovascular disease among children with chronic kidney disease in Gaza strip. J Cardiovasc Dis Res (2012) 0.75

Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs. Int J Nephrol Renovasc Dis (2008) 0.75

Medication-prescribing patterns of primary care physicians in chronic kidney disease. Clin Exp Nephrol (2013) 0.75

Articles by these authors

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (2006) 18.74

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet (2011) 13.10

Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med (2009) 10.60

Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med (2014) 9.25

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med (2012) 8.88

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ (2006) 7.80

Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet (2014) 6.23

Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25

Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab (2008) 4.61

Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med (2005) 4.57

Update in vitamin D. J Clin Endocrinol Metab (2010) 4.48

Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol (2007) 4.17

Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat (2005) 4.14

Marine pelagic ecosystems: the west Antarctic Peninsula. Philos Trans R Soc Lond B Biol Sci (2007) 4.10

Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial. Lancet (2014) 4.05

New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation (2003) 3.79

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet (2015) 3.79

Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med (2005) 3.57

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev (2004) 3.56

Analyses of cancer data from three ezetimibe trials. N Engl J Med (2008) 3.44

Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med (2011) 3.27

Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol (2006) 3.09

Effects of phosphate binders in moderate CKD. J Am Soc Nephrol (2012) 2.92

The natural history of the normal first stage of labor. Obstet Gynecol (2010) 2.85

Recent changes in phytoplankton communities associated with rapid regional climate change along the western Antarctic Peninsula. Science (2009) 2.83

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant (2010) 2.70

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet (2011) 2.50

Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol (2009) 2.45

Randomized clinical trials--removing unnecessary obstacles. N Engl J Med (2013) 2.43

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol (2012) 2.41

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease. Am J Kidney Dis (2005) 2.36

Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science (2013) 2.34

Prospective study of ultraviolet radiation exposure and mortality risk in the United States. Am J Epidemiol (2013) 2.30

1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol (2009) 2.22

When to stop pushing: effects of duration of second-stage expulsion efforts on maternal and neonatal outcomes in nulliparous women with epidural analgesia. Am J Obstet Gynecol (2009) 2.12

New-onset diabetes after transplantation: a threat to graft and patient survival. Lancet (2005) 2.11

Comparison of electronic data capture (EDC) with the standard data capture method for clinical trial data. PLoS One (2011) 2.06

Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol (2002) 2.02

Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. J Bone Miner Res (2002) 1.94

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One (2012) 1.93

Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol (2004) 1.89

Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol (2003) 1.87

Vitamin D and placental-decidual function. J Soc Gynecol Investig (2004) 1.79

IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol (2008) 1.79

Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis (2004) 1.76

Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.74

Anticoagulants in heart disease: current status and perspectives. Eur Heart J (2007) 1.73

Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab (2010) 1.72

Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis (2010) 1.65

EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int (2005) 1.64

Vitamin D in defense of the human immune response. Ann N Y Acad Sci (2007) 1.63

Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet (2003) 1.58

Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res (2005) 1.58

Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod (2006) 1.57

Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe (2009) 1.55

Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. PLoS Med (2011) 1.54

Relationship between semen parameters and spontaneous pregnancy. Fertil Steril (2009) 1.53

Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal study. Clin Infect Dis (2010) 1.52

Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology (2010) 1.51

1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis (2009) 1.51

Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol (2010) 1.50

Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr (2010) 1.48

Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab (2010) 1.48

Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol (2005) 1.45

Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization. Endocrinology (2008) 1.45

Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology (2008) 1.44

T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A (2010) 1.42

The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am J Pathol (2002) 1.41

Salt wars. Nephrol Dial Transplant (2008) 1.40

Vitamin D: beyond bone. Ann N Y Acad Sci (2013) 1.39

The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Cancer Res (2003) 1.38

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease. Thromb Haemost (2013) 1.36

Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int (2008) 1.36

Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. Clin J Am Soc Nephrol (2007) 1.34

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J (2004) 1.34

The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD. Am J Kidney Dis (2006) 1.31

Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J Biol Chem (2005) 1.26

Comparison of two expert-based assessments of diesel exhaust exposure in a case-control study: programmable decision rules versus expert review of individual jobs. Occup Environ Med (2012) 1.25

Reaching millennium development goal 4 - the Gambia. Trop Med Int Health (2011) 1.25

25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab (2002) 1.24

Prospective study of ultraviolet radiation exposure and risk of cancer in the United States. Int J Cancer (2012) 1.23

Antiplatelet agents for the treatment and prevention of atherothrombosis. Eur Heart J (2011) 1.23

Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS One (2011) 1.22

The impact of population-based identification of chronic kidney disease using estimated glomerular filtration rate (eGFR) reporting. Nephrol Dial Transplant (2007) 1.20

Back to the future: a new look at 'old' vitamin D. J Endocrinol (2008) 1.20